Maternal and obstetric complications among HIV-infected women treated with highly active antiretroviral treatment at a Regional Hospital in Durban, South Africa
- PMID: 29303121
- DOI: 10.4103/njcp.njcp_328_16
Maternal and obstetric complications among HIV-infected women treated with highly active antiretroviral treatment at a Regional Hospital in Durban, South Africa
Abstract
Introduction: HIV is the leading cause of maternal deaths in resource-poor countries. The use of highly active antiretroviral treatment (HAART) has been shown to almost eliminate vertical transmission and improve maternal health outcomes. Its effect on direct obstetric conditions has not been well documented.
Methods: We conducted a retrospective study of women who delivered at a regional hospital from April 1, 2011, to April 30, 2014. We employed a stratified random selection, where the first 50 files recorded in the birth register during each calendar month were chosen, at a ratio of one HIV uninfected for every 4 infected women.
Results: We analyzed files belonging to 302 HIV-uninfected women and 1159 HIV-infected women. The latter were further subdivided into those who used zidovudine, n = 424; those who initiated HAART prepregnancy, n = 312; and those who initiated in-pregnancy HAART, n = 423. We found that despite the use of HAART, HIV-infected women were at increased risk of both respiratory and lower genital tract infections (P = 0.009 and 0.001 respectively), compared to HIV-uninfected women. The women receiving HAART before pregnancy had an increased risk of preterm births (P = 0.004), and poor perinatal outcomes (P = 0.002); however, postpartum complications were reduced (P = 0.023). There was a trend toward an increased risk of preeclampsia (P = 0.064).
Conclusion: The initiation of HAART before pregnancy reduces the frequency of postpartum complications. However, compared to HIV-negative women, women receiving HAART prepregnancy remained at risk of infectious morbidity, had poor perinatal outcomes, and may also be at an increased risk of preeclampsia.
Similar articles
-
The impact of highly active antiretroviral therapy on obstetric conditions: A review.Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:126-131. doi: 10.1016/j.ejogrb.2016.12.008. Epub 2016 Dec 9. Eur J Obstet Gynecol Reprod Biol. 2017. PMID: 28013100 Review.
-
Effect of highly active antiretroviral treatment (HAART) during pregnancy on pregnancy outcomes: experiences from a PMTCT program in western India.AIDS Patient Care STDS. 2013 Mar;27(3):163-70. doi: 10.1089/apc.2012.0401. AIDS Patient Care STDS. 2013. PMID: 23477457
-
Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.AIDS Rev. 2011 Oct-Dec;13(4):198-213. AIDS Rev. 2011. PMID: 21975356 Review.
-
Pregnancy outcome among HIV positive women receiving antenatal HAART versus untreated maternal HIV infection.J Coll Physicians Surg Pak. 2011 Jun;21(6):356-9. J Coll Physicians Surg Pak. 2011. PMID: 21711992
-
Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.Med Wieku Rozwoj. 2003 Oct-Dec;7(4 Pt 1):459-68. Med Wieku Rozwoj. 2003. PMID: 15010556 Clinical Trial.
Cited by
-
Adverse perinatal outcomes attributable to HIV in sub-Saharan Africa from 1990 to 2020: Systematic review and meta-analyses.Commun Med (Lond). 2023 Jul 22;3(1):103. doi: 10.1038/s43856-023-00331-8. Commun Med (Lond). 2023. PMID: 37481594 Free PMC article.
-
Immunoexpression of neuropilin-1 in the chorionic villi of HIV-infected preeclamptic South African women of African ancestry.Histochem Cell Biol. 2023 Oct;160(4):307-319. doi: 10.1007/s00418-023-02213-5. Epub 2023 Jun 11. Histochem Cell Biol. 2023. PMID: 37302087 Free PMC article.
-
Adverse perinatal outcomes associated with antiretroviral therapy in women living with HIV: A systematic review and meta-analysis.Front Med (Lausanne). 2023 Feb 3;9:924593. doi: 10.3389/fmed.2022.924593. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36816720 Free PMC article.
-
Antiretroviral Options and Treatment Decisions During Pregnancy.Paediatr Drugs. 2023 May;25(3):267-282. doi: 10.1007/s40272-023-00559-w. Epub 2023 Feb 2. Paediatr Drugs. 2023. PMID: 36729360 Review.
-
Neuropilin-1 in the pathogenesis of preeclampsia, HIV-1, and SARS-CoV-2 infection: A review.Virus Res. 2022 Oct 2;319:198880. doi: 10.1016/j.virusres.2022.198880. Epub 2022 Jul 26. Virus Res. 2022. PMID: 35905790 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous